Taiwania Capital Management Corporation
VC Fund
Taipei, Taiwan
Taiwania Capital Management Corporation is a VC fund in Taipei focused on Software and Health Care. Taiwania Capital is a venture capital firm that establishes partnership with worldwide companies and to boost Taiwan’s economic growth.
- Total investments:
- 132
- Last investment:
- Lead investor:
- 48%
- Fund size:
- $194M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Taiwania Capital Management Corporation invests in
Stages Taiwania Capital Management Corporation invests in
Countries Taiwania Capital Management Corporation invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $3M–$11M
- Series A
- $3M–$64M
- Series B
- $11M–$55M
Investment Focus
Industry
- Software 24 (18%)
- Health Care 21 (16%)
- Artificial Intelligence 19 (14%)
- Biotechnology 18 (14%)
- Manufacturing 15 (11%)
Stage
- Series A 33 (25%)
- Series B 24 (18%)
- Seed 15 (11%)
- Convertible Note 9 (7%)
- Series C 7 (5%)
Country
- United States 42 (32%)
- Taiwan 25 (19%)
- China 4 (3%)
- United Kingdom 3 (2%)
- Croatia 2 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Cheng Wu
General Partner
|
General Partner | Total investments: 12 | Find email | |
|
David Weng
CEO
|
CEO | Total investments: 10 | Find email | |
Michael Huang
Managing Partner
|
Managing Partner | Total investments: 13 | Find email | |
Michael Shieh
Entrepreneur In Residence
|
Entrepreneur In Residence | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Shape Memory Medical Inc is a medical device company based in Santa Clara, California, founded to commercialize innovative medical devices based on Shape Memory Polymer (SMP) materials that were developed at Texas A&M University and Lawrence Livermore National Laboratory. The company is dedicated to developing innovative therapeutic solutionsfor peripheral vascular, cardiovascular, and neurovascular markets.Shape Memory Medical's device is the first to introduce an FDA-cleared medical device utilizing shape memory polymer (SMP) technology to a vascular market, enabling physicians to improve patient care. The Shape Memory Medical team has extensive experience with the SMP foam technology and the commercialization of medical devices. | $10M / Convertible Note / Aug 23, 2026 | ||
| Luxonis is a spatial AI and CV platform that focuses on embedded machine learning and computer vision technology. The company also develops human-Level Perception in embedded systems with permissive open-source MIT-licensed Hardware, software, and AI-Training. | $14M / Series A / Jul 02, 2026 | ||
| Arincare offers pharmacy management solution for pharmacists. | Series B / Jun 04, 2026 | ||
| HavocAI is an artificial intelligence company that offers maritime autonomy solutions to the defense and commercial markets. | $100M / Series A / May 12, 2026 | ||
| Skeleton Technologies is a manufacturer and developer of high-energy and high-power-density ultracapacitors based on patented curved graphene material. The company delivers high-power and high-energy storage solutions across the industry.The company's ultracapacitors deliver twice the energy density and four times the power density offeredby other manufacturers. The company's current customer base includes engineering companies, the European Space Agency, and several Tier 1 automotive manufacturers. | $38.7M / Venture - Series Unknown / May 08, 2026 | ||
| Alcatraz AI replaces badging as an access point identification method by leveraging facial recognition, 3d sensing, and AI. The company builds a facial authentication platform using AI and 3D sensing to enable a highly secure and frictionless entry into physical locations. Alcatraz AI was founded in 2016 and is headquartered in California, USA. | $50M / Series B / Apr 01, 2026 | ||
| Orqa is a technology company enablling FPV (First Person View) and Remote Reality (RR) for autonomous and remotely operated vehicles. | $14.8M / Series A / Mar 10, 2026 | ||
| Resemble AI creates custom voices using proprietary deep-learning models that can produce realistic speech synthesis. It allows users to transform their voice into the target voice with real-time speech-to-speech. Granular control over every inflection and intonation. | $13M / Dec 07, 2025 | ||
| HavocAI is an artificial intelligence company that offers maritime autonomy solutions to the defense and commercial markets. | $85M / Series A / Oct 09, 2025 | ||
| Supernova connects to popular design editors and interprets design systems into data. These data can then be transformed in powerful ways to create code for product development, for literally any coding stack or platform imaginable. These transformations can be fully automated so that when design changes occur, the code is automatically updatedto reflect the changes. Developers can fully control how the code is rendered, literally down to the individual code characters. An ecosystem of Supernova-developed and community-maintained code export packages is available for popular stacks and platforms via the Supernova Store, or teams can choose to create their own — for instance, to support proprietary frameworks or to customize code output to meet any company guidelines. | $9.2M / Series A / Sep 30, 2025 | ||
| See all 132 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Taiwania Capital Management Corporation invest in?
Taiwania Capital Management Corporation invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Series A and Series B stage. Most of the 132 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Taiwania Capital Management Corporation invest in?
Taiwania Capital Management Corporation typically joins rounds of $3M–$11M at Seed, $3M–$64M at Series A and $11M–$55M at Series B. These are whole funding-round sizes, not Taiwania Capital Management Corporation's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Taiwania Capital Management Corporation took part in.
How do I contact Taiwania Capital Management Corporation?
Public channels for Taiwania Capital Management Corporation include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Taiwania Capital Management Corporation?
The team at Taiwania Capital Management Corporation includes Cheng Wu (General Partner), David Weng (CEO) and Michael Huang (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
